You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Androgen Receptor Antagonists

Showing 1 - 25 of 9,369
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
  • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 4, 2023

Breast Cancer With or Without BRCA Mutation

Recruiting
  • Breast Cancer
  • Androgen receptor status and BRCA mutation
  • Varanasi, UP, India
    Banaras Hindu University
Jun 2, 2022

Androgen Deprivation Therapy, Prostate Cancer, Hypertension Trial (Gonadotropin-Releasing Hormone Agonist, Androgen receptor

Not yet recruiting
  • Androgen Deprivation Therapy
  • +4 more
  • Gonadotropin-Releasing Hormone Agonist
  • +2 more
  • (no location specified)
Jan 18, 2023

Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy-induced Nausea and Vomiting
  • Hanzhou, Zhejiang, China
    the Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023

Prostate Cancer Trial in Atlanta, Charleston (Opaganib, Abiraterone, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Atlanta, Georgia
  • +1 more
Dec 28, 2022

Primary Aldosteronism Trial in Montréal (Renin measurements)

Not yet recruiting
  • Primary Aldosteronism
  • Renin measurements
  • Montréal, Quebec, Canada
    Hôpital du Sacré-Coeur de Montréal
Oct 30, 2023

Renin Angiotensin Aldosterone System Genetic Polymorphism on

Recruiting
  • Myocardial Infarction
    • Cairo, Egypt
      Ain Shams University
    May 16, 2023

    Pediatric Cancer Trial in Yerevan (Ondansetron, Dexamethasone)

    Not yet recruiting
    • Pediatric Cancer
    • Yerevan, Armenia
      Hematology Center named after prof. R. Yeolyan
    May 23, 2023

    Heart Failure Trial (Finerenone, Placebo)

    Not yet recruiting
    • Heart Failure
    • (no location specified)
    Sep 11, 2023

    IL-6 and Its Receptor Antagonists in Children's Severe Sepsis.

    Withdrawn
    • Critical Illness Sepsis, Severe
      • (no location specified)
      Jun 13, 2022

      Alcohol Use Disorder Trial in Columbus (Suvorexant, Placebo)

      Recruiting
      • Alcohol Use Disorder
      • Columbus, Ohio
        The Ohio State University
      Dec 11, 2022

      Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

      Not yet recruiting
      • Prostate Cancer
      • Prostate Adenocarcinoma
      • (no location specified)
      Feb 2, 2023

      IL-1ß and Its Receptor Antagonists in Treatment of Severe

      Withdrawn
      • Critical Illness
      • Sepsis, Severe
        • (no location specified)
        Jun 13, 2022

        Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

        Recruiting
        • Advanced Breast Carcinoma
        • +17 more
        • Houston, Texas
          M D Anderson Cancer Center
        Dec 5, 2022

        Urothelial Carcinoma Bladder, Androgen Receptor Positive Trial in Providence (Degarelix, Gemcitabine/Cisplatin)

        Not yet recruiting
        • Urothelial Carcinoma Bladder
        • Androgen Receptor Positive
        • Providence, Rhode Island
          Lifespan Cancer Institute
        May 1, 2023

        Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

        Not yet recruiting
        • Triple Negative Breast Cancer
        • +2 more
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Jul 25, 2023

        s to Learn More About Treatment With Steroidal Mineralocorticoid

        Active, not recruiting
        • Chronic Kidney Disease
        • +2 more
        • sMRA therapies
        • Whippany, New Jersey
          Many Locations
        Jan 30, 2023

        Primary Hyperaldosteronism Due to Adrenal Adenoma Trial in Gothenburg, Stockholm, Umeå (Unilateral adrenalectomy, Medical

        Not yet recruiting
        • Primary Hyperaldosteronism Due to Adrenal Adenoma
        • Unilateral adrenalectomy
        • Medical treatment (eplerenone)
        • Gothenburg, Sweden
        • +2 more
        Mar 30, 2023

        Physical Function During ARSI Treatment

        Recruiting
        • Advanced Prostate Carcinoma
        • androgen receptor signaling inhibitors
        • Chapel Hill, North Carolina
          Lineberger Comprehensive Cancer Center at University of North Ca
        Nov 8, 2022

        Salivary Gland Carcinoma Trial in United States (Goserelin Acetate, Pembrolizumab)

        Recruiting
        • Salivary Gland Carcinoma
        • Chicago, Illinois
        • +6 more
        Sep 22, 2022

        Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

        Not yet recruiting
        • Breast Cancer
        • Beijing, Benjing, China
        • +2 more
        Dec 30, 2022

        Interleukin 6 Receptor Antagonists in Corona Virus Disease 19

        Recruiting
        • Corona Virus Infection
        • ELISA
        • Assiut, Egypt
          AssiutU
        Feb 2, 2023

        Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative Trial in United States (drug, other, biological)

        Active, not recruiting
        Has Results
        • Androgen Receptor Positive
        • +5 more
        • Corona, California
        • +6 more
        Jun 8, 2022

        Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

        Recruiting
        • Castration-Resistant Prostatic Cancer
        • +4 more
        • Orange City, Florida
        • +1 more
        Nov 23, 2022

        In-vitro Diagnostic Test to Predict COVID-19 Mortality and

        Recruiting
        • SARS-CoV 2
        • +5 more
        • CAG length <22
        • CAG length >=22
        • Madrid, Spain
          Hospital Universitario Ramon y Cajal
        Feb 17, 2022